Oppenheimer Reiterates Outperform Rating on MindMed (MNMD) Following P2 IIT Publication Data
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois reiterated an Outperform rating and $52.00 price target on MindMed (NASDAQ: MNMD) as a recent publication ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
